FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050652223> ?p ?o ?g. }

• W2050652223 endingPage "446" @default.
• W2050652223 startingPage "439" @default.
• W2050652223 abstract "Objective: To evaluate the efficacy of eicosapentaenoic acid (EPA) against ribavirin (RBV)-associated hemolytic anemia during the first 12 weeks in chronic hepatitis C virus (HCV) combination therapy. Methods: This study was a prospective open-label, randomized controlled trial. 100 HCV patients were randomized to either the EPA group (n = 49) or non-EPA group (n = 51) who received combination therapy with or without EPA. We compared the changes in hemoglobin level and RBV plasma concentrations at week 12 in each group with RBV dose reduction rate and performed multivariate analysis to identify independent variables associated with RBV dose reduction. Results: 8 patients (17%) in the EPA group and 20 patients (29%) in the non-EPA group required RBV dose reduction, respectively. The cumulative RBV reduction rate was significantly lower in the EPA group than in the non-EPA group (p = 0.017), while the decrease of hemoglobin and RBV plasma concentrations from baseline was not significantly different. However, in the multivariate analysis, treatment with EPA showed significant variables for the reduction of RBV dose (odds ratio 3.235, p = 0.023). Conclusion: EPA could prevent the RBV dose reduction during the first 12 weeks in combination therapy, although further large-scale double-blind randomized controlled trials are required." @default.
• W2050652223 created "2016-06-24" @default.
• W2050652223 creator A5019195799 @default.
• W2050652223 creator A5019763674 @default.
• W2050652223 creator A5021748063 @default.
• W2050652223 creator A5022484621 @default.
• W2050652223 creator A5023958825 @default.
• W2050652223 creator A5026178160 @default.
• W2050652223 creator A5027196488 @default.
• W2050652223 creator A5034077858 @default.
• W2050652223 creator A5045008956 @default.
• W2050652223 creator A5060767540 @default.
• W2050652223 creator A5067970141 @default.
• W2050652223 creator A5073894165 @default.
• W2050652223 creator A5084015574 @default.
• W2050652223 creator A5087512403 @default.
• W2050652223 date "2007-01-01" @default.
• W2050652223 modified "2023-09-24" @default.
• W2050652223 title "Eicosapentaenoic Acid Could Permit Maintenance of the Original Ribavirin Dose in Chronic Hepatitis C Virus Patients during the First 12 Weeks of Combination Therapy with Pegylated Interferon-α and Ribavirin" @default.
• W2050652223 cites W1599050129 @default.
• W2050652223 cites W1970823932 @default.
• W2050652223 cites W1974441545 @default.
• W2050652223 cites W1975105404 @default.
• W2050652223 cites W1977256895 @default.
• W2050652223 cites W1978339383 @default.
• W2050652223 cites W1992239172 @default.
• W2050652223 cites W2007209701 @default.
• W2050652223 cites W2011707824 @default.
• W2050652223 cites W2014616917 @default.
• W2050652223 cites W2016205218 @default.
• W2050652223 cites W2027545702 @default.
• W2050652223 cites W2039441730 @default.
• W2050652223 cites W2043872599 @default.
• W2050652223 cites W2054586386 @default.
• W2050652223 cites W2060255885 @default.
• W2050652223 cites W2075293916 @default.
• W2050652223 cites W2085261733 @default.
• W2050652223 cites W2087073512 @default.
• W2050652223 cites W2090204589 @default.
• W2050652223 cites W2090370866 @default.
• W2050652223 cites W2092167363 @default.
• W2050652223 cites W2092710527 @default.
• W2050652223 cites W2093155138 @default.
• W2050652223 cites W2100227035 @default.
• W2050652223 cites W2113552969 @default.
• W2050652223 cites W2127685726 @default.
• W2050652223 cites W2156574153 @default.
• W2050652223 cites W2162945799 @default.
• W2050652223 cites W2165715544 @default.
• W2050652223 cites W2317554121 @default.
• W2050652223 cites W2328171401 @default.
• W2050652223 cites W2332630894 @default.
• W2050652223 cites W2333452860 @default.
• W2050652223 doi "https://doi.org/10.1159/000114718" @default.
• W2050652223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18253048" @default.
• W2050652223 hasPublicationYear "2007" @default.
• W2050652223 type Work @default.
• W2050652223 sameAs 2050652223 @default.
• W2050652223 citedByCount "8" @default.
• W2050652223 countsByYear W20506522232012 @default.
• W2050652223 countsByYear W20506522232016 @default.
• W2050652223 countsByYear W20506522232021 @default.
• W2050652223 crossrefType "journal-article" @default.
• W2050652223 hasAuthorship W2050652223A5019195799 @default.
• W2050652223 hasAuthorship W2050652223A5019763674 @default.
• W2050652223 hasAuthorship W2050652223A5021748063 @default.
• W2050652223 hasAuthorship W2050652223A5022484621 @default.
• W2050652223 hasAuthorship W2050652223A5023958825 @default.
• W2050652223 hasAuthorship W2050652223A5026178160 @default.
• W2050652223 hasAuthorship W2050652223A5027196488 @default.
• W2050652223 hasAuthorship W2050652223A5034077858 @default.
• W2050652223 hasAuthorship W2050652223A5045008956 @default.
• W2050652223 hasAuthorship W2050652223A5060767540 @default.
• W2050652223 hasAuthorship W2050652223A5067970141 @default.
• W2050652223 hasAuthorship W2050652223A5073894165 @default.
• W2050652223 hasAuthorship W2050652223A5084015574 @default.
• W2050652223 hasAuthorship W2050652223A5087512403 @default.
• W2050652223 hasConcept C126322002 @default.
• W2050652223 hasConcept C168563851 @default.
• W2050652223 hasConcept C178790620 @default.
• W2050652223 hasConcept C185592680 @default.
• W2050652223 hasConcept C19038510 @default.
• W2050652223 hasConcept C203014093 @default.
• W2050652223 hasConcept C2522874641 @default.
• W2050652223 hasConcept C2776091944 @default.
• W2050652223 hasConcept C2776408679 @default.
• W2050652223 hasConcept C2776461080 @default.
• W2050652223 hasConcept C2776999253 @default.
• W2050652223 hasConcept C2780040827 @default.
• W2050652223 hasConcept C543025807 @default.
• W2050652223 hasConcept C71924100 @default.
• W2050652223 hasConcept C90924648 @default.
• W2050652223 hasConceptScore W2050652223C126322002 @default.
• W2050652223 hasConceptScore W2050652223C168563851 @default.
• W2050652223 hasConceptScore W2050652223C178790620 @default.
• W2050652223 hasConceptScore W2050652223C185592680 @default.
• W2050652223 hasConceptScore W2050652223C19038510 @default.
• W2050652223 hasConceptScore W2050652223C203014093 @default.

• next